Literature DB >> 18381995

States and substance abuse treatment programs: funding and guidelines for infection-related services.

Steven Kritz1, Lawrence S Brown, R Jeffrey Goldsmith, Edmund J Bini, Jim Robinson, Donald Alderson, Patricia Novo, John Rotrosen.   

Abstract

Community-based substance abuse treatment programs provide HIV, hepatitis C virus, and sexually transmitted infection services. To explore how state funding and guidelines affect practice, we surveyed state agency administrators and substance abuse treatment program administrators and clinicians regarding 8 infection-related services. Although state funding for infection-related services is widely available, substance abuse treatment programs do not always access it. Substance abuse treatment program guidelines are clearer in states that have written guidelines. Improved communication between state agencies and substance abuse treatment programs may enhance service.

Entities:  

Mesh：

Year:  2008        PMID： 18381995      PMCID： PMC2374831          DOI： 10.2105/AJPH.2007.119578

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


  16 in total

1.  Risk and prevalence of treatable sexually transmitted diseases at a Birmingham substance abuse treatment facility.

Authors:  L H Bachmann; I Lewis; R Allen; J R Schwebke; L C Leviton; H A Siegal; E W Hook
Journal:  Am J Public Health       Date:  2000-10       Impact factor: 9.308

2.  HIV infection and AIDS risk behaviors among injecting drug users entering methadone treatment: an update.

Authors:  R J Battjes; R W Pickens; L S Brown
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1995-09-01

Review 3.  Reciprocal interactions between human immunodeficiency virus and hepatitis C virus infections.

Authors:  H Zylberberg; S Pol
Journal:  Clin Infect Dis       Date:  1996-11       Impact factor: 9.079

4.  A population-based study of sexually transmitted disease incidence and risk factors in human immunodeficiency virus-infected people.

Authors:  E A Belongia; R N Danila; V Angamuthu; C D Hickman; J M DeBoer; K L MacDonald; M T Osterholm
Journal:  Sex Transm Dis       Date:  1997-05       Impact factor: 2.830

5.  Substance abuse and HIV infection.

Authors:  Henry Francis
Journal:  Top HIV Med       Date:  2003 Jan-Feb

6.  HIV risk-related sex behaviors among injection drug users, crack smokers, and injection drug users who smoke crack.

Authors:  R E Booth; J K Watters; D D Chitwood
Journal:  Am J Public Health       Date:  1993-08       Impact factor: 9.308

7.  Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995.

Authors:  B Broers; C Junet; M Bourquin; J J Déglon; L Perrin; B Hirschel
Journal:  AIDS       Date:  1998-10-22       Impact factor: 4.177

8.  Health services for HIV/AIDS, HCV, and sexually transmitted infections in substance abuse treatment programs.

Authors:  Lawrence S Brown; Steven Kritz; R Jeffrey Goldsmith; Edmund J Bini; Jim Robinson; Donald Alderson; John Rotrosen
Journal:  Public Health Rep       Date:  2007 Jul-Aug       Impact factor: 2.792

9.  Prevalence and incidence of hepatitis C virus infection among young adult injection drug users.

Authors:  R S Garfein; M C Doherty; E R Monterroso; D L Thomas; K E Nelson; D Vlahov
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1998

Review 10.  Correlates of hepatitis C virus infections among injection drug users.

Authors:  D L Thomas; D Vlahov; L Solomon; S Cohn; E Taylor; R Garfein; K E Nelson
Journal:  Medicine (Baltimore)       Date:  1995-07       Impact factor: 1.889
View more
  11 in total

1.  Substance abuse treatment as HIV prevention: more questions than answers.

Authors:  Lawrence S Brown; Steven Kritz; Edmund J Bini; Ben Louie; Jim Robinson; Donald Alderson; John Rotrosen
Journal:  J Natl Med Assoc       Date:  2010-12       Impact factor: 1.798

2.  Barriers to providing health services for HIV/AIDS, hepatitis C virus infection and sexually transmitted infections in substance abuse treatment programs in the United States.

Authors:  Edmund J Bini; Steven Kritz; Lawrence S Brown; Jim Robinson; Don Alderson; John Rotrosen
Journal:  J Addict Dis       Date:  2011-04

3.  Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs.

Authors:  Amanda J Abraham; Lauren A O'Brien; Hannah K Knudsen; Brian E Bride; G Rush Smith; Paul M Roman
Journal:  J Subst Abuse Treat       Date:  2012-04-25

4.  Determinants of the availability of hepatitis C testing services in opioid treatment programs: results from a national study.

Authors:  Jemima A Frimpong; Thomas D'Aunno; Lan Jiang
Journal:  Am J Public Health       Date:  2014-04-17       Impact factor: 9.308

5.  NIDA's Clinical Trials Network: an opportunity for HIV research in community substance abuse treatment programs.

Authors:  Susan Tross; Aimee N C Campbell; Donald A Calsyn; Lisa R Metsch; James L Sorensen; Steven Shoptaw; Louise Haynes; George E Woody; Robert M Malow; Lawrence S Brown; Daniel J Feaster; Robert E Booth; Raul N Mandler; Carmen Masson; Beverly W Holmes; Grant Colfax; Audrey J Brooks; Denise A Hien; Bruce R Schackman; P Todd Korthuis; Gloria M Miele
Journal:  Am J Drug Alcohol Abuse       Date:  2011-09       Impact factor: 3.829

6.  HIV/AIDS services in private substance abuse treatment programs.

Authors:  Amanda J Abraham; Lauren A O'Brien; Brian E Bride; Paul M Roman
Journal:  Drug Alcohol Depend       Date:  2010-12-08       Impact factor: 4.492

7.  Disparities in Health Services for HIV/AIDS, Hepatitis C Virus, and Sexually Transmitted Infections: Role of Substance Abuse Treatment Programs.

Authors:  Lawrence S Brown; Steven Kritz; Adashima Muhammad; Edmund J Bini; R Jeffrey Goldsmith; Jim Robinson; Donald Alderson; Deborah S Hasin; John Rotrosen
Journal:  J Addict Med       Date:  2009-06       Impact factor: 3.702

8.  Perceived implementation of the Office of Alcoholism and Substance Abuse Services (OASAS) tobacco-free regulation in NY State and clinical practice behaviors to support tobacco cessation: a repeated cross-sectional study.

Authors:  Lillian T de Tormes Eby; Tanja C Laschober
Journal:  J Subst Abuse Treat       Date:  2013-01-30

9.  Low Rates of Adoption and Implementation of Rapid HIV Testing in Substance Use Disorder Treatment Programs.

Authors:  Jemima A Frimpong; Thomas D'Aunno; Stéphane Helleringer; Lisa R Metsch
Journal:  J Subst Abuse Treat       Date:  2015-12-28

10.  A qualitative analysis of provider barriers and solutions to HIV testing for substance users in a small, largely rural southern state.

Authors:  Patricia B Wright; Geoffrey M Curran; Katharine E Stewart; Brenda M Booth
Journal:  J Rural Health       Date:  2013-03-25       Impact factor: 4.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.